Award
National Cancer Institute 11086646
Development of a Wearable, Non-Invasive, Treatment Device for Metastatic Triple-Negative Breast Cancer (TNBC)
Recipient
EMBIOSYS INC.
Award Amount
$188,875.00
Ceiling
$188,875.00
Awarded
June 18, 2025
Identifier
11086646
NIH funded project to develop a wearable, non-invasive treatment device for metastatic triple-negative breast cancer, focusing on safety and efficacy in preclinical models.
Description
The project involves developing a wearable, non-invasive device for treating metastatic TNBC using induced electric field (iEF) technology. The work aims to establish safety, assess adverse effects, and evaluate efficacy in mouse models. The project aims to improve treatment options for patients with metastatic TNBC who are unresponsive to current therapies.